Skip to main content
Molecules logoLink to Molecules
. 2023 Jul 6;28(13):5248. doi: 10.3390/molecules28135248

The Prediction of Antioxidant Q-Markers for Angelica dahurica Based on the Dynamics Change in Chemical Compositions and Network Pharmacology

Hui Gao 1, Qian Li 1,*
Editor: Nqobile Masondo1
PMCID: PMC10343566  PMID: 37446909

Abstract

Objective: To clarify the accumulation and mutual transformation patterns of the chemical components in Angelica dahurica (A. dahurica) and predict the quality markers (Q-Markers) of its antioxidant activity. Method: The types of and content changes in the chemical components in various parts of A. dahurica during different periods were analyzed by using gas chromatography-mass spectrometry technology (GC-MS). The antioxidant effect of the Q-Markers was predicted using network pharmacological networks, and molecular docking was used to verify the biological activity of the Q-Markers. Result: The differences in the content changes in the coumarin compounds in different parts were found by using GC-MS technology, with the relative content being the best in the root, followed by the leaves, and the least in the stems. The common components were used as potential Q-Markers for a network pharmacology analysis. The component-target-pathway-disease network was constructed. In the molecular docking, the Q-Markers had a good binding ability with the core target, reflecting better biological activity. Conclusions: The accumulation and mutual transformation patterns of the chemical components in different parts of A. dahurica were clarified. The predicted Q-Markers lay a material foundation for the establishment of quality standards and a quality evaluation.

Keywords: Angelica dahurica, GC-MS, antioxidant, network pharmacology, Q-Markers

1. Introduction

The herbal medicine known as Angelica dahurica (Hoffm.) Benth. & Hook.f. ex Franch. & Sav. is the dry root of A. dahurica (Fisch, ex Hoffm.) Benth.et Hook. f. or A. dahurica (Fisch. ex Hoffm.) Benth.et Hook. f. var. formosana (Boiss.) Shan et Yuan [1]. It was first documented in Sheng Nong’s Herbal Classic and listed as a middle grade. Angelica dahurica (A. dahurica) is a perennial herb and its entire growth period is three years. The year of planting is the seedling period and the second year is the vegetative growth period, which is harvested when the plant withers. The plants collecting seeds enter the reproductive growth period in the third year [2]. The vegetative growth stage of A. dahurica can be divided into four stages: the seedling stage from mid-September to early March of the next year, the leaf growth stage from early March to early May, the root growth stage from early May to mid-July, and the harvest stage from mid-July to mid-September [3]. At present, A. dahurica has only root medicine, but Wang et al. [4] found that, in addition to root medicine, there are also records of leaf medicine. The chemical compositions of its different medicinal parts are obviously different, and these chemical compositions and pharmacological activity change greatly in different periods [5]. Therefore, the various parts of A. dahurica were studied according to its different growth periods to clarify the accumulation and mutual transformation laws of the chemical components in these different parts.

The pharmacological effects of A. dahurica extracts include antioxidant [6], anti-inflammatory [7], immunoregulation [8], antitumor [9], and anti-Alzheimer [10] effects. In recent years, experts have used a variety of modern analytical techniques to conduct in-depth research on the pharmacological effects and chemical components of A. dahurica [11,12]. They have shown that [13,14] it mainly contains coumarin and volatile oil, as well as polysaccharides, glycosides, trace elements, and other effective ingredients. Network pharmacology, a research method that conforms to the multi-component and multi-target effects of traditional Chinese medicine, has emerged in recent years, expanding research directions and providing new ideas for the study of the mechanism of action of traditional Chinese medicine. It predicts potential targets as a whole and quickly and extensively screens them through a network analysis of the drug component target [15,16,17]. Due to the multi-component and multi-target characteristics of traditional Chinese medicine, detecting any of its components cannot represent its overall efficacy, and due to the complexity of traditional Chinese medicine, the quality control indicators of this traditional Chinese medicine have a low correlation with their effectiveness and a poor specificity. Therefore, Liu’s group [18] first proposed the concept of quality markers (Q-markers) in 2016, aiming to better control the quality of traditional Chinese medicine.

Therefore, this study used gas chromatography-mass spectrometry (GC-MS) technology to study the accumulation dynamics of the chemical components in different parts of A. dahurica, analyzing the differences in the types and contents of these chemical components in its roots, stems, and leaves at different stages, and clarifying the accumulation and mutual transformation laws of the chemical components in these different parts. Four common components of the different parts of A. dahurica from different periods were screened out, these common components were analyzed as Q-Markers for network pharmacology, and their targets of action and involved signaling pathways were searched. Finally, a “component-target- pathway-disease” network was established to explore the specific mechanism of A. dahurica’s antioxidant activity. Finally, the biological activity of the Q-Markers was verified through molecular docking technology.

2. Results and Discussion

2.1. Analysis of Chemical Constituents in Different Parts of A. dahurica

Sample solutions of the roots, stems, and leaves of A. dahurica were analyzed using GC-MS technology to obtain the total ion flow diagrams of the mass spectrometry of its various parts. The total ion flow chart of the period can be compared with the highest accumulation of the compound content and types in each part, as shown in Figure 1. It can be concluded that, if the total ion flow diagram of each part is different, the type and content of the compound are different.

Figure 1.

Figure 1

Total ion flow diagram of chemical components in A. dahurica at different parts. Notes: (A) root (B) stem (C) leaf.

The chemical components and their relative contents in the roots, stems, and leaves of A. dahurica in different periods were obtained through the retrieval and analysis of the NIST14 standard mass spectrum library (Table 1). Sixty-one and forty-two compounds were identified in the roots and leaves in early September, and forty-eight compounds were identified in the stems in mid-July. Among them, the highest content in the roots was psoralen, the highest content in the stems was 5-hydroxymethylfurfural, and the highest content in the leaves was β-eudesmol. It can be seen that early September was the period with the most kinds of compounds in A. dahurica, and also the period with the most content accumulation.

Table 1.

Analysis of chemical constituents of A. dahurica.

No. RT Compound Molecular Formula Relative Content (%)
Root Leaf Stem
1 10.730 Hexanal C6H12O 0.0630 0.0458 0.4852
2 11.065 Phenyl α-D-glucopyranoside C12H16O6 0.0618 0.2091 -
3 11.175 1-Heptanol C7H16O 0.3544 1.1326 0.1893
4 11.735 Thymol C10H14O 0.0870 0.1836 0.2834
5 12.467 3-Carene C10H16 4.6076 0.2972 0.2763
6 12.930 3-Furaldehyde C5H4O2 2.7352 0.4450 0.1074
7 13.216 Camphene C19H16 0.0574 0.0574 -
8 13.770 3-Furanmethanol C5H6O2 3.2033 2.2195 0.4839
9 14.032 (1S)-(-)-β-Pinene C10H16 1.1364 0.0125 0.4001
10 15.056 2-Butenoicacid,2-methyl-, (Z)- C5H8O2 2.7235 0.4160 0.5282
11 15.117 3-Methylcrotonaldehyde C5H8O 3.4739 1.5817 -
12 15.410 2,6-Dimethylocta-2,7-dien-6-ol C10H18O 1.7658 0.2394 1.1417
13 15.562 α-Phellandrene C10H16 1.0273 0.4106 0.3924
14 16.884 4-Isopropylidene-1-methylcyclo C10H16 0.8403 - 0.1160
15 17.774 Borneol C10H18O 0.3705 0.1086 0.2096
16 19.718 4-Hydroxy-2,5-dimethyl-3(2H) furanone C6H8O3 1.5613 - 0.8221
17 20.382 Acetone Glucose C9H16O6 0.0652 0.2013 0.0567
18 21.503 4,6-O-Ethylidene-α-D-glucose C8H14O6 0.9665 0.3251 -
19 22.356 Isopimpinellin C13H10O5 0.5048 1.1532 0.9114
20 23.014 Isolongifolene C15H24 0.8128 - 0.0789
21 23.051 Isobornyl acetate C12H20O2 1.2771 - -
22 23.143 Nonanal C9H18O7 0.0889 0.6421 0.3161
23 24.197 Pimpinellin C13H10O5 0.0828 0.2033 -
24 25.444 2-Hydroxy-5-methyl acetophenone C9H10O2 3.5660 4.2425 -
25 25.988 5-Hydroxymethylfurfural C6H6O3 3.6589 4.8772 0.3453
26 26.415 9-Hexadecenoic acid, (9Z)- C16H30O2 1.1248 - 1.3593
27 26.805 Vetiverol C15H26O 0.3599 - -
28 26.823 β-Eudesmol C15H26O 0.2134 1.0981 14.5071
29 27.055 Angenomalin C14H12O3 7.5490 0.7771 -
30 27.085 Bisabolene C15H24 2.0434 0.6263 0.6706
31 28.402 Paeonol C9H10O3 0.8024 0.4961 0.9929
32 29.005 Acrylic acid tetradecyl ester C17H32O2 0.7908 - 0.1187
33 29.249 Bergapten C12H8O4 3.6443 0.3544 0.9598
34 30.126 Phellopterin C17H16O5 0.2227 0.5170 0.2085
35 30.797 1-Hexadecene C16H32 0.1534 0.3363 0.3949
36 30.803 Phenyl stearate C24H40O2 0.0939 2.4649 -
37 31.376 Osthole C15H16O3 1.4983 0.9714 0.6746
38 32.065 (+)-Decursinol C14H14O4 1.1992 0.5716 1.5293
39 33.619 Imperatorin C16H14O4 4.9971 0.7366 0.4191
40 33.997 2-Octylcyclopropaneoctanal C19H36O 0.2201 0.2357 -
41 34.198 Pabulenol C16H14O5 0.4830 0.2332 0.1453
42 35.417 Isooxypeucedanin C16H14O5 0.2401 0.4490 0.2430
43 35.581 Isoimperatorin C16H14O4 0.2248 0.2321 -
44 36.325 Methyl hexadecanoate C17H34O2 1.0761 1.0578 5.0586
45 36.520 11-Dodecen-1-ol acetate C14H26O2 0.0066 - 0.1124
46 36.648 Oxypeucedanin C16H14O5 1.2500 0.3575 0.6478
47 38.184 Byakangelicol C17H16O6 0.2069 0.2795 0.1002
48 40.231 Psoralen C11H6O3 10.3183 0.1749 0.2499
49 40.445 Angelicin C11H6O3 0.4101 - -
50 41.798 13-Octadecenal, (Z)- C18H34O 0.1218 0.0844 -
51 41.840 Verbenalin C17H24O 0.0512 - 0.1104
52 42.023 1,2-Benzenedicarboxylic acid C16H22O4 0.0543 - -
53 42.096 Byakangelicin C17H18O7 0.1309 0.0391 -
54 42.535 Dibutyl phthalate C16H22O4 1.8615 - -
55 43.669 Methyl oleate C19H36O2 0.6757 0.7178 0.7278
56 43.894 Decursin C19H20O5 3.8667 2.5107 1.4460
57 44.224 Methyl Stearate C19H38O2 0.7647 0.3617 1.0879
58 45.735 Meranzin C15H16O4 0.0411 0.3364 -
59 46.704 Columbianadin C19H20O5 1.0762 0.1896 0.4628
60 48.983 1,4-Benzenedicarboxaldehyde,2,5-bis(hexyloxy)- C20H30O4 0.1152 - 0.1347
61 50.141 Paullinic acid C20H38O2 0.0291 - -

2.2. Analysis of Main Chemical Components in Different Parts of A. dahurica at Different Stages

2.2.1. Analysis of Chemical Components in the Roots of A. dahurica in Different Periods

In this study, imperatorin, oxypeucedanin, psoralen, and bergapten were used as representative coumarins to analyze the chemical components of A. dahurica at different stages. Imperatorin is the required analytical marker for A. dahurica stipulated in the Pharmacopoeia of the People’s Republic of China. According to the literature, the contents of oxypeucedanin, psoralen, and bergapten in A. dahurica are high and have very extensive pharmacological activities. Therefore, the four coumarins were selected for a subsequent chemical composition analysis.

The relative content of the compounds in the roots of A. dahurica in different periods was analyzed using the peak area normalization method, and an accumulation dynamic analysis of the four important, effective components in the roots was carried out (Figure 2). As an index component of A. dahurica stipulated in the Pharmacopoeia of the People’s Republic of China, the relative content of imperatorin gradually increased from the seedling stage in March to the harvest stage in September, and rapidly increased from early May to mid-July. The relative content reached a maximum of 4.9971% in early September and began to decrease in November. Among the four components in the same period, psoralen had the highest relative content, reaching 10.3183% in early September. The relative content of oxypeucedanin was the lowest, followed by bergapten.

Figure 2.

Figure 2

Changes in chemical components in roots of A. dahurica in different periods.

The relative content of coumarin in the root of A. dahurica in different periods increased first and then decreased. During the period of vegetative growth, from early March to early September, the coumarin content in root gradually increased, and the coumarin compound content reached its maximum in early September. After November, it entered the reproductive growth period. In order to maintain its life metabolism, the root system consumed some dry matter, so the relative content of coumarin showed a downward trend. This period was not conducive to an improvement in the quality of A. dahurica. To sum up, the coumarin content of the roots in the second year of growth showed an “S” trend.

2.2.2. Analysis of Chemical Components in the Stems of A. dahurica in Different Periods

It can be seen from Figure 3 that the change in the coumarins in the stems of A. dahurica in different periods first increased and then decreased. From early March to mid-July, the aerial part was in a rapid growth period, so the relative content of the four coumarins gradually rose, and this content reached its maximum in mid-July. The highest relative content was imperatorin (0.7366%), followed by oxypeucedanin and bergapten, and the lowest content was psoralen, which is different from the results in the roots. After July, the contents of imperatorin, psoralen, and bergapten all showed a gradual downward trend, but oxypeucedanin began to rise again in September, and the total relative content was lower than that in the middle of July.

Figure 3.

Figure 3

Changes in chemical components in stems of A. dahurica in different periods.

To sum up, mid-July is the period for the greatest accumulation of chemical compounds in the stems of A. dahurica. This indicated that coumarin compounds began to accumulate in the stems and transported less to the roots during the long period of leaf growth (from early March to early May). However, during root growth (from early May to mid-July), the coumarin compounds in the stems began to be transported to the underground part, and their own synthesis rate slowed down. In the harvest period especially (from mid-July to mid-September), a large amount of effective ingredients accumulated in the roots to promote the yield formation and improve the quality, which led to a decrease in the coumarin compounds content and species in the stems in early September.

2.2.3. Analysis of Chemical Components in the Leaves of A. dahurica in Different Periods

It can be seen from Figure 4 that the relative content of the four coumarins gradually increased from early March to early September. The contents of imperatorin, oxypeucedanin, and psoralen reached the highest in early September, and the content of coumarin in the leaves decreased with the decrease in temperature in early November, but bergapten still increased gradually in November. The content of imperatorin increased rapidly in early September, reaching 0.4191%. The highest content of the four coumarins was bergapten (0.9598%), followed by imperatorin and oxypeucedanin, and the lowest content was psoralen (0.2499%).

Figure 4.

Figure 4

Changes in chemical components in leaves of A. dahurica in different periods.

To sum up, the total content of the chemical components in the A. dahurica leaves reached the highest in early September. The content of the coumarin compounds increased the fastest in the leaf growth period (from early March to early May), indicating that, with an increase in leaf area, more and more photosynthetic products were produced, and the coumarin compounds produced by the leaves increased rapidly. However, when the root growth rate increased, the leaves began to show a gradual aging trend, and the growth rate of the coumarin content in the leaves gradually decreased.

2.2.4. Analysis of the Difference in Compound Accumulation in Different Medicinal Parts of A. dahurica

Table 2 shows the number of compounds identified in the different medicinal parts of A. dahurica at different stages. The results showed that the number of chemical compounds in the roots, stems, and leaves presented an “S” type change. In early March, there were more compounds in the stems than in the roots and leaves. From early May, the types of the compounds in the roots began to increase rapidly, exceeding those in the stems and leaves. The accumulation of compounds in the roots, stems, and leaves showed different trends. In the early September, the number of compounds in the roots and leaves was the largest, while in mid-July, the number of compounds in the stems was the largest. To sum up, most kinds of compounds were in the roots, followed by the stems and leaves.

Table 2.

Number of compounds in A. dahurica in different parts at different periods.

Part March May July September November
Root 22 42 54 61 49
Leaf 24 38 48 41 30
Stem 20 34 39 42 35

The content changes in the four representative coumarins in the different parts of A. dahurica in the same period can be compared, as shown in Figure 5. In early March, imperatorin only existed in the roots and stems, and its content in the stems was higher than that in the roots. In early May, its content in the roots increased rapidly, and imperatorin also appeared in the leaves. From early May to early November, the relative content of imperatorin was maintained as root > stem > leaf. In early March, oxypeucedanin only existed in the stems and leaves, and in early May, it appeared in the roots, and the relative content was leaf > stem > root. In mid-July, the content of oxypeucedanin in the roots increased rapidly, and the content was higher than that in the stems and leaves, reaching the highest in early September. Psoralen only existed in the roots in early March, appeared in the stems in early May, and appeared in the leaves in mid-July, but its content in the roots was the highest, and its content in the stems and leaves was low. Its content in the leaves was higher than that in the stems from early September to November. In early March, bergapten was present in the roots, stems, and leaves, and the content of bergapten was maintained in the order of leaves > stems > roots from March to May. In mid-July, the content of bergapten in the roots began to increase, and after that, the content remained as root > leaf > stem. To sum up, the content relationship of the different parts of A. dahurica was: root > leaf > stem, indicating that the accumulation of coumarin in A. dahurica in the late growth period is mainly in the root.

Figure 5.

Figure 5

Changes in chemical components in A. dahurica in different parts at different periods.

2.3. Network Pharmacological Analysis

2.3.1. The Potential Q-Markers of A. dahurica

A total of 61 chemical components of A. dahurica were retrieved using a GC-MS database. Based on the common components of its various parts at different stages, four compounds were ultimately selected as the Q-Markers of A. dahurica, including imperatorin, oxypeucedanin, psoralen, and bergapten. Their structures are shown in Figure 6.

Figure 6.

Figure 6

Structures of Q-Markers of A. dahurica.

2.3.2. Q-Markers Targets and Antioxidant Targets

The Q-Markers obtained using GC-MS were searched through the TCMSP database and predicted based on the Swiss Target Prediction database platform. The Gene Names of the target genes were collected using the Uniprot database and duplicate or invalid targets were deleted. A total of 81 target genes of the Q-Markers in A. dahurica were obtained. A total of 1424 antioxidant-related targets were searched and screened in the Genecards and OMIM databases. The active ingredient targets and disease targets were mapped (Figure 7), resulting in 61 intersecting targets, which are potential antioxidant targets of A. dahurica (Table 3).

Figure 7.

Figure 7

Potential antioxidant targets of Q-Markers in A. dahurica.

Table 3.

Cross-target prediction of Q-Markers and diseases.

NO. Target Common Name Uniprot ID
1 Monoamine oxidase A MAOA P21397
2 Acetylcholinesterase ACHE P22303
3 Beta-secretase 1 BACE1 P56817
4 Cytochrome P450 1A2 CYP1A2 P05177
5 Cytochrome P450 19A1 CYP19A1 P11511
6 MAP kinase p38 alpha MAPK14 Q16539
7 Nitric oxide synthase, inducible NOS2 P35228
8 Nerve growth factor receptor Trk-A NTRK1 P04629
9 Histone deacetylase 2 HDAC2 Q92769
10 Tyrosine-protein kinase JAK2 JAK2 O60674
11 Histone deacetylase 1 HDAC1 Q13547
12 Serine/threonine-protein kinase mTOR MTOR P42345
13 PI3-kinase p110-beta subunit PIK3CB P42338
14 PI3-kinase p110-gamma subunit PIK3CG P48736
15 PI3-kinase p110-alpha subunit PIK3CA P42336
16 Phosphodiesterase 5A PDE5A O76074
17 Heat shock factor protein 1 HSF1 Q00613
18 Muscle glycogen synthase GYS1 P13807
19 Protein tyrosine kinase 2 beta PTK2B Q14289
20 Monoamine oxidase B MAOB P27338
21 MAP kinase-activated protein kinase 2 MAPKAPK2 P49137
22 c-Jun N-terminal kinase 1 MAPK8 P45983
23 Protoporphyrinogen oxidase PPOX P50336
24 Prostanoid EP2 receptor PTGER2 P43116
25 Butyrylcholinesterase BCHE P06276
26 Cannabinoid receptor 1 CNR1 P21554
27 Cyclooxygenase-1 PTGS1 P23219
28 Cyclooxygenase-2 PTGS2 P35354
29 Cannabinoid receptor 2 CNR2 P34972
30 Dual specificity mitogen-activated protein kinase kinase 1 MAP2K1 Q02750
31 Tyrosine-protein kinase JAK1 JAK1 P23458
32 Platelet activating factor receptor PTAFR P25105
33 Nuclear factor NF-kappa-B p105 subunit NFKB1 P19838
34 Quinone reductase 1 NQO1 P15559
35 Estrogen receptor alpha ESR1 P03372
36 Ribosomal protein S6 kinase 1 RPS6KB1 P23443
37 Poly [ADP-ribose] polymerase-1 PARP1 P09874
38 Intercellular adhesion molecule-1 ICAM1 P05362
39 Selectin E SELE P16581
40 Endothelin receptor ET-B EDNRB P24530
41 Endothelin receptor ET-A EDNRA P25101
42 Heat shock protein HSP 90-alpha HSP90AA1 P07900
43 Arachidonate 5-lipoxygenase ALOX5 P09917
44 Leucine-rich repeat serine/threonine-protein kinase 2 LRRK2 Q5S007
45 Androgen Receptor AR P10275
46 Aldo-keto-reductase family 1 member C3 AKR1C3 P42330
47 Caspase-3 CASP3 P42574
48 Caspase-9 CASP9 P55211
49 Caspase-7 CASP7 P55210
50 Myeloperoxidase MPO P05164
51 Cyclin-dependent kinase 2 CDK2 P24941
52 Cyclin-dependent kinase 4 CDK4 P11802
53 Xanthine dehydrogenase XDH P47989
54 Aldo-keto reductase family 1 member C1 AKR1C1 Q04828
55 Estrogen receptor beta ESR2 Q92731
56 Aldose reductase AKR1B1 P15121
57 Insulin receptor INSR P06213
58 Focal adhesion kinase 1 PTK2 Q05397
59 Tyrosine-protein kinase TIE-2 TEK Q02763
60 Heat shock 70 kDa protein 1 HSPA1A P0DMV8
61 Tyrosine-protein kinase Lyn (by homology) LYN P07948

2.3.3. PPI Network of Potential Antioxidant Targets of A. dahurica

A total of 61 intersecting targets were obtained by intersecting the Q-Markers of A. dahurica with potential antioxidant targets. Then, a PPI network was created using these intersecting targets. As shown in Figure 8, the PPI had a total of 60 nodes and 353 edges, with 2 potential targets not involved in the protein interactions (PTAFR and PPOX). These two potential targets were removed.

Figure 8.

Figure 8

Target protein PPI network for antioxidant activity of Q-Markers in A. dahurica.

2.3.4. Enrichment of Antioxidant GO Function and Analysis of KEGG Pathway in A. dahurica

The GO functional enrichment was analyzed through a database and it could be seen that there were 245 biological processes (BP) involved in the potential antioxidant targets of A. dahurica, mainly including its response to lipopolysaccharide, protein phosphorylation, the negative regulation of the apoptotic process, protein autophosphorylation, and its response to xenobiotic stimuli, etc. There were a total of 35 cellular components (CC), mainly involving the membrane raft, cytosol, cytoplasm, perinuclear region of the cytoplasm, and neuronal cell bod, etc. There were a total of 84 molecular functions (MF), including the protein series/threonine/tyrosine kinase activity, enzyme binding, protein kinase activity, ATP binding, and protein binding, etc. Among the three, p < 0.05 was selected and the top 20 counts were used for the GO functional enrichment map (Figure 9).

Figure 9.

Figure 9

Analysis of antioxidant in Q-Markers of A. dahurica by GO Functional Enrichment.

The KEGG pathway enrichment was analyzed and the results showed that the potential targets of the antioxidant effects of A. dahurica mainly involved pathways such as the pathways in cancer, Kaposi-sarcoma-associated herpesvirus infection, lipid and atherosclerosis, human cytomegalovirus infection, and the PI3K-Akt signaling pathway, etc. p < 0.05 was selected and the top 20 counts were used for the KEGG pathway map (Figure 10). The KEGG pathway was consistent with the pharmacological activities of A. dahurica, including its antioxidant, anti-inflammatory, and anti-tumor effects, proving that it could effectively predict the pharmacological effects.

Figure 10.

Figure 10

Enrichment analysis of antioxidant KEGG pathway in Q-Markers of A. dahurica.

2.3.5. Molecular Docking

The top five core targets were selected from the PPI network using the MCC algorithm and the Cytohubba plugin, as shown in Figure 11.

Figure 11.

Figure 11

Core targets map of TOP 5.

The results of the molecular docking between the five core targets and Q-Markers are shown in Table 4. The binding energy represents the advantages and disadvantages of small molecules binding to the target proteins, and a binding energy of less than 0 indicated that small molecules could freely bind to these target proteins. The lower the binding energy, the higher the likelihood of this binding. The Q-Markers had a good combination ability with HSP90AA1, MTOR, CASP3, and ESR1 on the key targets, indicating that the predicted Q-Markers of A. dahurica has good biological activity. In this study, the docking results of imperatorin and HSP90AA1, oxypeucedanin and MTOR, psoralen and CASP3, and bergapten and ESR1, with good docking results, were selected for display (Figure 12).

Table 4.

Binding energy between Q-Markers and core targets.

Target Binding Energy (kcal/mol)
Imperatorin Oxypeucedanin Psoralen Bergapten
CASP3 −7.3 −5.0 −6.6 −6.5
ESR1 −7.3 −5.5 −6.3 −6.8
HSP90AA1 −7.7 −5.3 −4.7 −5.5
MTOR −7.4 −6.5 −6.4 −6.3
MAPK8 −6.1 −5.2 −5.6 −5.9
Figure 12.

Figure 12

Molecular docking results. Notes: (A) Imperatorin and HSP90AA1, (B) Oxypeucedanin and MTOR, (C) Psoralen and CASP3, and (D) Bergapten and ESR1.

The key antioxidant targets of A. dahurica include CASP3, ESR1, HSP90AA1, MTOR, and MAPK8. The Caspase family is a convergence point of multiple apoptotic pathways [19], among which Caspase 3 mainly plays a role in executing apoptosis and is closely related to cell apoptosis. It can affect the proliferation and apoptosis of tumor cells through various mechanisms of action [20,21]. ESR1 belongs to endocrine hormones and research has shown that the skin itself has endocrine and immune functions, which can regulate each other [22,23,24]. The gene of HSP90AA1 (commonly known as HSP90) is situated on the chromosomes 14q32.2 [25]. In current cancer therapy, HSP90 is the center of attraction for its ability to inhibit multiple signaling pathways simultaneously [26]. HSP90 has been highly expressed in multiple cancers, such as lung, ovarian, endometrial, and pancreatic cancer, and additionally oropharyngeal squamous cell carcinoma (OSCC) and various myeloma [27]. The latest study revealed that a high HSP90 expression was a poor prognosis marker in different cancers such as lung cancer, melanoma, esophageal cancer, bladder cancer, and leukemia [28]. MTOR is a hub for various important signaling pathways within cells, regulating translation initiation, transcription, protein synthesis, and degradation functions, as well as important physiological functions such as cell survival, proliferation, and apoptosis [29,30]. The MAPK pathway is involved in processes such as cell differentiation, migration, proliferation, apoptosis, and inflammation [31,32]. It can be speculated that the Q-Markers of A. dahurica, including imperatorin, oxypeucedanin, psoralen, and bergapten, can exert anti-inflammatory, immune, and oxidative effects by regulating target proteins such as MAPK1, MAPK8, ESR1, and ESR2.

3. Materials and Methods

3.1. Materials and Reagents

The plant materials of A. dahurica used in this experiment were all fresh materials from Wufeng Town (Yichang, China) from March (seedling stage), May (leaf-growing stage), July (root growth stage), September (harvest stage), and November (reproductive stage) in 2021, which were identified by Professor Yuan Chen (Department of Chinese Herbal Medicine, Gansu Agricultural University, Lanzhou, China). The voucher specimens (No. GAUAB-AD-20210310, No. GAUAB-AD-20210507, No. GAUAB-AD-20210716, No. GAUAB-AD-20210905, and No. GAUAB-AD-20211104) were deposited in the herbarium of the Department of Chinese herbal medicine, Agronomy building of Gansu Agricultural University, Lanzhou, China. The methanol (Lot 67-56-1, Chromatographic grade) was purchased from Tianjin Beichen Fangzheng Reagent Co., Ltd. (Tianjin, China).

3.2. Analyzing the Main Chemical Components in Various Parts of A. dahurica at Different Periods by GC-MS

3.2.1. Sample Solution Preparation

The A. dahurica in different periods was dried at 37 °C [33] and then crushed and sieved through 40 mesh. The medicinal powder of A. dahurica in different periods was weighed to 3 g, added to 30 mL of methanol in a conical flask, soaked for 30 min, extracted in a 40 °C water bath using ultrasound (power: 360 W, frequency: 40 KHz) for 30 min, cooled to room temperature, and then methanol was used to make up the lost weight. A certain amount of solution was taken into a centrifuge tube and centrifuged into a high-speed centrifuge (speed: 8000 r/min, time: 10 min), and then the supernatant was taken for 0.22 µm microporous membrane filtration to obtain the test solution.

3.2.2. GC-MS Conditions

The data were obtained using gas chromatography coupled with triple quadrupole mass spectrometry (Agilent 7890B-7000D, Agilent Technologies Co. Ltd., Palo Alto, CA, USA). GC-MS column: DB-23 (30 × 0.25 mm × 0.25 μm), the carrier gas was high-purity helium and its flow rate was 1.0 mL/min, the inlet temperature was 250 °C, the initial column temperature was 35 °C, and this was maintained for 7 min. The temperature was raised to 280 °C at the rate of 10 °C/min and the samples were incubated for 5 min. The split injection was 10:1 [34].

The mass spectrum conditions: the electron impact (EI) ion source, full scanning mode (mass range m/z 30–500), ion source temperature of 230 °C; interface temperature of 250 °C; quadrupole temperature of 150 °C; electronic energy of 70 eV; solvent delay time of 3 min; and the ion detection mode (SIM) was selected.

3.2.3. Data Analysis

GC-MS was used to conduct total ion scanning on the compound to obtain the total ion flow diagram of A. dahurica in different periods for its different parts. Through an analysis of the retention time and mass spectrum data of the compound, the obtained mass spectrum diagram was retrieved using the NIST14 standard mass spectrum library, and the chromatographic peak with a matching degree higher than 80% was selected for the qualitative identification of the compound. At the same time, the relative content of each component was calculated according to the peak area normalization method [35].

3.3. Prediction and Analysis of Antioxidant Related Substances in A. dahurica Based on Network Pharmacology

3.3.1. Obtaining the Q-Markers of A. dahurica

Four common components were identified in each period and part based on the chemical compositions of the various parts of A. dahurica during the different periods measured using GC-MS technology. The Q-Markers in A. dahurica were further selected as active ingredients, and a network pharmacology analysis was conducted on the antioxidant effect.

3.3.2. Screening of Q-Markers Targets

The selected Q-Markers were queried for Molecule Name in the TCMSP database (https://tcmsp-e.com/, accessed on 11 May 2023). Subsequently, the 3D structure and SMILES format of the compounds were obtained from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/, accessed on 11 May 2023), imported into the Swiss Target Prediction database (http://www.swisstargetprediction.ch/, accessed on 11 May 2023), and analyzed by clicking on “Predict targets” to output the compound target information. The obtained compound target information was imported into the UniProt database (https://www.uniprot.org/, accessed on 14 May 2023), the species “Homo sapiens” was selected, and Probability > 0 was used as the screening criterion to obtain the corresponding predicted target.

3.3.3. Screening of Potential Targets for Antioxidant Activity

The keyword “antioxidant” was entered into the GeneCards (https://www.genecards.org/, accessed on 15 May 2023) and OMIM databases (https://omim.org/, accessed on 16 May 2023) to search for the genes related to antioxidant activity in the database. The GeneCards database was screened using the median screening method to obtain score scores. All the antioxidant targets in the OMIM database were obtained, and then the duplicates were removed to obtain the disease targets related to antioxidant effects.

3.3.4. Protein Interaction Network Construction (PPI)

The intersection of the Q-Marker targets and potential antioxidant targets was taken, and a Venn diagram was drawn using the online website Venny 2.1.0 (https://bioinfogp.cnb.csic.es/tools/venny/index.html, accessed on 21 May 2023). The intersection target obtained was the potential target of A. dahurica’s antioxidant effect. The potential target of A. dahurica’s antioxidant effect was imported into the STRING database (https://cn.string-db.org/, accessed on 21 May 2023) to preliminarily obtain the protein interaction network of the antioxidant effect, and the relevant data were exported. A protein interaction network was constructed for the antioxidant target using the String database (https://cn.string-db.org/, accessed on 21 May 2023).

3.3.5. GO Enrichment Analysis and KEGG Pathway Analysis

The obtained anti-oxidation core target protein of A. dahurica was imported into the DAVID database (https://david.ncifcrf.gov/, accessed on 23 May 2023), and a Gene Ontology (GO) enrichment analysis and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis were obtained. Entries with p-values of <0.05 were selected as significantly enriched GO entries or KEGG pathways.

3.3.6. Molecular Docking

According to the degree values, the top 5 core targets were selected as key targets for the molecular docking visualization with the Q-Markers. Firstly, the SDF format file of the Q-Markers’ 2D structure was downloaded from the PubChem database, and the PDB format file of the core target protein 3D structure was downloaded from the RCSB database (https://www.rcsb.org/, accessed on 25 May 2023). Further processing of the protein and component data, such as hydrogenation and dehydration, was performed using Autodock Tools 1.5.6, which was saved in pdbqt format, and the binding energy was calculated.

4. Conclusions

In this study, the dynamic accumulation of the chemical components in different parts of A. dahurica at different stages was first investigated by using GC-MS technology. A total of 61 compounds were identified in A. dahurica, and the types and contents of the chemical components in each part were clarified. The relationship between the number and content of species in the roots, stems, and leaves was different. It could be found that, in the early stage, the stem and leaf growth was the main growth, while in the later stage, the root growth was the main growth. There was a clear competitive relationship between the aboveground and underground parts. Therefore, appropriate measures should be taken to control the growth of the aboveground part of A. dahurica after it enters the root growth peak period, so as to smoothly transfer the growth center from aboveground to underground and improve the quality of the medicinal material when using roots as medicine. The results of the network pharmacology research further explored the mechanism of the antioxidant effect of A. dahurica, indicating that this process involves multiple active ingredients, targets, and signaling pathways. Its mechanism of action is complex and diverse, and it is not only achieved through a single component, target, or the regulation of a single pathway, which is consistent with the multi-target characteristics of traditional Chinese medicine in treating diseases. The results of the macromolecular docking test showed that the active components of A. dahurica had a good binding ability with the core target related to antioxidants. In future studies, the spatial distribution of the compounds in different parts of Angelica dahurica at different stages and an experimental verification of the network pharmacology results could be carried out.

Author Contributions

Conceptualization, H.G. and Q.L.; data curation, H.G.; formal analysis, H.G.; investigation, H.G. and Q.L.; methodology, H.G. and Q.L.; project administration, Q.L.; supervision, Q.L.; validation, H.G.; writing—original draft, H.G.; writing—review and editing, Q.L. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

There are no conflict of interest to declare.

Sample Availability

Samples of the plant materials of A. dahurica are available from the authors.

Funding Statement

This work was supported by Gansu Province university teachers’ innovation fund project (2023A-53), Longyuan youth innovation and entrepreneurship talent project (2023-1), the National Natural Science Foundation of China (31860102), Youth Tutor Fund project of Gansu Agricultural University (GAU-QDFC-2020-2), Young Talents Introduction Projects of Gansu Agricultural University (GSAU-RCZX201704).

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Chinese Pharmacopoeia Commission . Pharmacopoeia of People’s Republic of China. Volume 1. China Medical Science and Technology Press; Beijing, China: 2020. p. 109. [Google Scholar]
  • 2.Zhao D.Y., Hao Q.X., Jin Y., Kang L.P., Liu Y., Guo L.P. Research progress on biological characteristics and cultivation techniques of Angelica dahurica. Mod. Chin. Tradit. Med. 2015;17:1188–1192. [Google Scholar]
  • 3.Lu Q. Master’s Thesis. Chengdu University of TCM; Chengdu, China: 2009. Comparative Study on the Growth Characteristics and Yield and Quality of Chuan Bai Zhi; p. 11. [Google Scholar]
  • 4.Wang M.Y., Jia M.R., Ma Y.Y., Jiang G.H., Tang S.W., Xia L. Effects of different medicinal parts and different processing methods on the content of coumarins in Angelica dahurica. Tradit. Chin. Med. 2004;27:826–828. [PubMed] [Google Scholar]
  • 5.Zhang W.L., Zheng K.Y., Zhu K.Y., Zhan J.Y., Bi C.W., Chen J.P., Dong T.X., Choi C.Y., Lau T.W., Tsim K.W. Chemical and biological assessment of angelica roots from different cultivated regions in a Chinese herbal decoction danggui buxue tang. Evid.-Based Complement. Altern. Med. 2013;2013:483286. doi: 10.1155/2013/483286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pang X., Jing Y., Li P., Qiu X., Zheng Y., Wang Q., Wu L. Structural characterization and antioxidant activities of polysaccharides from A. dahurica as extracted by optimized ultrasonic-assisted method. Int. J. Food Prop. 2022;25:1635–1649. doi: 10.1080/10942912.2022.2096066. [DOI] [Google Scholar]
  • 7.Mehnaz P., Md A.H., Trishna D., Seung Y.L., Sa R.P., Beong O.L. Antioxidant, anti-inflammatory and antiproliferative activity of A. dahurica root extracts. J. Food Biochem. 2014;38:281–292. [Google Scholar]
  • 8.Wang H., Wang X., Zhou L., Zhang S., An L., Bao J., Li Z., Sun Y., Li Y., Cui J., et al. Structural characteristics and in vitro and in vivo immunoregulatory properties of a gluco-arabinan from A. dahurica. Int. J. Biol. Macromol. 2021;183:90–100. doi: 10.1016/j.ijbiomac.2021.04.077. [DOI] [PubMed] [Google Scholar]
  • 9.Zhang Y., Li Z., Wei J., Kong L., Song M., Zhang Y., Xiao X., Cao H., Jin Y. Network pharmacology and molecular docking reveal the mechanism of A. dahurica against Osteosarcoma. Medicine. 2022;101:2196. doi: 10.1097/MD.0000000000032389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shu P., Li J., Fei Y., Zhu H., Yu M., Liu A., Niu H., Zou S., Wei X., Ju Z., et al. Isolation, structure elucidation, tyrosinase inhibitory, and antioxidant evaluation of the constituents from A. dahurica roots. J. Nat. Med. 2020;74:456–462. doi: 10.1007/s11418-019-01375-8. [DOI] [PubMed] [Google Scholar]
  • 11.Li D., Wu L. Coumarins from the roots of A. dahurica cause anti-allergic inflammation. Exp. Ther. Med. 2017;14:874–880. doi: 10.3892/etm.2017.4569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhao H., Feng Y.L., Wang M., Wang J.J., Liu T., Yu J. The A. dahurica: A review of traditional uses, phytochemistry and pharmacology. Front. Pharmacol. 2022;13:896637. doi: 10.3389/fphar.2022.896637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cheng W., Tao W., Limin H., Wen L., Jie Z., Huaizhen H. Synthesis and fluorescent study of 5-phenyl furocoumarin derivatives as vasodilatory agents. Bioorg. Med. Chem. Lett. 2016;26:640–644. doi: 10.1016/j.bmcl.2015.11.056. [DOI] [PubMed] [Google Scholar]
  • 14.Li B., Zhang X., Wang J., Zhang L., Gao B., Shi S., Wang X., Li J., Tu P. Simultaneous characterisation of fifty coumarins from the roots of Angelica dahurica by off-line two-dimensional high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry. Phytochem. Anal. PCA. 2014;25:229–240. doi: 10.1002/pca.2496. [DOI] [PubMed] [Google Scholar]
  • 15.Liu J., Liu C., Chen H., Cen H., Yang H., Liu P., Liu F., Ma L., Chen Q., Wang L. Tongguan capsule for treating myocardial ischemia-reperfusion injury: Integrating network pharmacology and mechanism study. Pharm. Biol. 2023;61:437–448. doi: 10.1080/13880209.2023.2175877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Deng H., Jiang J., Zhang S., Wu L., Zhang Q., Sun W. Network pharmacology and experimental validation to identify the potential mechanism of Hedyotis diffusa Willd against rheumatoid arthritis. Sci. Rep. 2023;13:1425. doi: 10.1038/s41598-022-25579-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zheng Y., Wang Y., Xia M., Song Y., Gao Y., Zhang L., Zhang C. Investigation of the hemostatic mechanism of Gardeniae fructus Praeparatus based on pharmacological evaluation and network pharmacology. Ann. Transl. Med. 2022;10:2399462. doi: 10.21037/atm-21-6415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lu X.L., Chen S.L., Xiao X.H. Quality Mark (Q-Marker): A New Concept of Quality Control for Traditional Chinese Medicine Product. Chin. Tradit. Herb. Drugs. 2016;47:1443–1457. [Google Scholar]
  • 19.Treat M.D., Marlon A.J., Samentar L., Caberoy N., van Breukelen F. Mitigating Apoptotic and Inflammatory Signaling via Global Caspase Inhibition in Hibernating Ground Squirrels, Spermophilus lateralis. Physiol. Biochem. Zool. PBZ. 2023;96:53–61. doi: 10.1086/722133. [DOI] [PubMed] [Google Scholar]
  • 20.Mukai M.A., Kusama T., Hamanaka Y. Cross alk between apoptosis and invasion signaling in cancer through caspase-3 activation. Cancer Res. 2005;65:9121–9125. doi: 10.1158/0008-5472.CAN-04-4344. [DOI] [PubMed] [Google Scholar]
  • 21.Zhao K., Han D., He S., Wu L., Liu W., Zhong Z. N-acetyl-L-cysteine attenuates oxidative stress-induced bone marrow endothelial cells apoptosis by inhibiting BAX/caspase 3 pathway. Biochem. Biophys. Res. Commun. 2023;656:115–121. doi: 10.1016/j.bbrc.2023.03.045. [DOI] [PubMed] [Google Scholar]
  • 22.Liu F., Tian L., Tan J., Li Z., Qin H., Xu D., Huang Z., Wu X., Chen G., Wu Q., et al. Identification of a novel ESR1 mutation in a Chinese PCOS woman with estrogen insensitivity in IVF treatment. Reprod. Biol. Endocrin. 2022;20:157. doi: 10.1186/s12958-022-01029-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ren H., Liu H., Huang L., Xie W., Lin D., Luo D. Association of ESR1 and ESR2 Polymorphisms with Osteoporosis: A meta-analysis from 36 studies. J. Clin. Densitom. Off. J. Int. Soc. Clin. Densitom. 2022;25:699–711. doi: 10.1016/j.jocd.2022.08.007. [DOI] [PubMed] [Google Scholar]
  • 24.Klaas M., Mäemets A.K., Heinmäe E., Lagus H., Arak T., Eller M., Kingo K., Kankuri E., Jaks V. Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades. Cell. Mol. Life Sci. 2022;79:157. doi: 10.1007/s00018-022-04202-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ruiz M.I.G., Floor K., Roepman P., Rodriguez J.A., Meijer G.A., Mooi W.J., Jassem E., Niklinski J., Muley T., van Zandwijk N., et al. Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target. PLoS ONE. 2008;3:e0001722. doi: 10.1371/journal.pone.0001722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Workman P., Burrows F., Neckers L., Rosen N. Drugging the Cancer Chaperone HSP90: Combinatorial Therapeutic Exploitation of Oncogene Addiction and Tumor Stress. Ann. N. Y. Acad. Sci. 2007;1113:202–216. doi: 10.1196/annals.1391.012. [DOI] [PubMed] [Google Scholar]
  • 27.Patel K., Wen J., Magliocca K., Muller S., Liu Y., Chen Z.G., Saba N., Diaz R. Heat Shock Protein 90 (HSP90) is Overexpressed in p16-Negative Oropharyngeal Squamous Cell Carcinoma, and Its inhibition in Vitro Potentiates the Effects of Chemoradiation. Cancer Chemother. Pharmacol. 2014;74:1015–1022. doi: 10.1007/s00280-014-2584-8. [DOI] [PubMed] [Google Scholar]
  • 28.Huang T., Chen S., Han H., Li H., Huang Z., Zhang J., Yin Q., Wang X., Ma X., Dai P., et al. Expression of Hsp90α and Cyclin B1 Were Related to Prognosis of Esophageal Squamous Cell Carcinoma and Keratin Pearl Formation. Int. J. Clin. Exp. Pathol. 2014;7:1544–1552. [PMC free article] [PubMed] [Google Scholar]
  • 29.Frias M.A., Hatipoglu A., Foster D.A. Regulation of mTOR by phosphatidic acid. Trends Endocrinol. Metab. TEM. 2023;34:170–180. doi: 10.1016/j.tem.2023.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rattis B.A.C., Piva H.L., Duarte A., Gomes F.G.F.L., Lellis J.R., Soave D.F., Ramos S.G., Tedesco A.C., Celes M.R.N. Modulation of the mTOR pathway by curcumin in the heart of septic mice. Pharmaceutics. 2022;14:2277. doi: 10.3390/pharmaceutics14112277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhou T.S., Yang L. NOX4micro RNA-363-3p reduces endotheial cell inflammatory responses in coronary heart disease via inactivation of the-dependent p38 MAPKaxis. Aging. 2021;13:11061–11082. doi: 10.18632/aging.202721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sultonov D., Kim Y.H., Park H., Kim K. Intermittent hypoxia on the attenuation of induced nasal allergy and allergic asthma by MAPK signaling pathway downregulation in a mice animal model. Int. J. Mol. Sci. 2022;23:9235. doi: 10.3390/ijms23169235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhang Z.M. Ph.D. Thesis. China Agricultural University; Beijing, China: 2005. Studies on Quality Character Formation and Cultivation Regulation and Control of Angelica dahurica; p. 9. [Google Scholar]
  • 34.Yang H., Li Q. Optimization of extraction process and the antioxidant activity spectrum-effect relationship of Angelica dahurica. Biomed. Chromatogr. BMC. 2022;36:e5322. doi: 10.1002/bmc.5322. [DOI] [PubMed] [Google Scholar]
  • 35.Chen Y.Y., Li Q., Qiu D.Y. The dynamic accumulation rules of chemical components in different medicinal parts of angelica sinensis by GC-MS. Molecules. 2022;27:4617. doi: 10.3390/molecules27144617. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.


Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES